GAMCO Investors’s Filana Therapeutics FLNA Stock Holding History

GAMCO Investors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,000	Closed	-$68K	–	844
2017 Q4	$68K	Sell	17,000 -3,000	-15%	-$12.1K	﹤0.01%	831
2017 Q3	$81K	Buy	20,000 +7,000	+54%	+$25K	﹤0.01%	838
2017 Q2	$54K	Sell	13,000 -2,714	-17%	-$12.8K	﹤0.01%	833
2017 Q1	$98K	Hold	15,714	–	–	﹤0.01%	829
2016 Q4	$63K	Buy	15,714 +6,428	+69%	+$29.8K	﹤0.01%	810
2016 Q3	$65K	Hold	9,286	–	–	﹤0.01%	804
2016 Q2	$142K	Hold	9,286	–	–	﹤0.01%	788
2016 Q1	$145K	Hold	9,286	–	–	﹤0.01%	772
2015 Q4	$114K	Hold	9,286	–	–	﹤0.01%	791
2015 Q3	$119K	Hold	9,286	–	–	﹤0.01%	806
2015 Q2	$112K	Sell	9,286 -714	-7%	-$9.78K	﹤0.01%	814
2015 Q1	$132K	Sell	10,000 -2,143	-18%	-$28.9K	﹤0.01%	815
2014 Q4	$173K	Sell	12,143 -2,143	-15%	-$37.1K	﹤0.01%	827
2014 Q3	$391K	Sell	14,286 -7,143	-33%	-$217K	﹤0.01%	764
2014 Q2	$863K	Sell	21,429 -4,285	-17%	-$159K	﹤0.01%	663
2014 Q1	$990K	Sell	25,714 -1,429	-5%	-$50.4K	0.01%	621
2013 Q4	$923K	Sell	27,143 -8,571	-24%	-$228K	﹤0.01%	622
2013 Q3	$680K	Sell	35,714 -6,429	-15%	-$112K	﹤0.01%	661
2013 Q2	$652K	Buy	+42,143	New	+$891K	﹤0.01%	637

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

GAMCO Investors's FLNA Position: Q1 2018 in Review

GAMCO Investors sold out of Filana Therapeutics (FLNA) in Q1 2018, closing a stake of 17,000 shares — an estimated $68K sold.

GAMCO Investors first reported a position in FLNA in Q2 2013 and held it in 19 quarters. The position peaked at $990K in Q1 2014. 26 funds tracked by Wall St. Rank hold FLNA as of Q1 2018.

GAMCO Investors reported no remaining Filana Therapeutics position as of Q1 2018 after selling out during the quarter.
GAMCO Investors sold 17,000 Filana Therapeutics shares in Q1 2018, an estimated $68K.
GAMCO Investors first reported a position in Filana Therapeutics in Q2 2013 and held it in 19 quarters.
GAMCO Investors's Filana Therapeutics position peaked at $990K in Q1 2014.
26 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2018.

Based on GAMCO Investors's 13F filing for Q1 2018, filed 9 May 2018.